Program stages
Our pipeline is organized by discovery, preclinical development, early clinical testing and later-stage evaluation. Each program follows defined milestones for safety assessment, biomarker strategy, and regulatory engagement.
Milestones and timelines
We publish anticipated milestones at a program level where appropriate. For confidential program status or investor requests, qualified parties may request additional information by contacting investors@codytherapeutics.com.
Access to details
Full development data and non-public program details are available under controlled disclosure agreements. To discuss collaborations, licensing or data access, email partnerships@codytherapeutics.com.